Glucagon-like peptide 1 receptor agonist use and risk of arthroplasty for knee osteoarthritis: retrospective database analysis.

Regional anesthesia and pain medicine

Acute glucagon-like peptide-1 receptor agonist, semaglutide, attenuates cue-, drug-, and stress-induced fentanyl seeking in male Sprague-Dawley rats.

Behavioural pharmacology

15-PGDH inhibition promotes muscle repair and strength recovery during GLP-1 receptor agonist-induced weight loss.

Proceedings of the National Academy of Sciences of the United States of America

Cost-Effectiveness and Budget-Impact Analysis of Semaglutide in Heart Failure with Preserved Ejection Fraction and Obesity in the German Health-Care System.

PharmacoEconomics

Renal or Hepatic Impairment Does Not Affect Pharmacokinetics, Safety, or Tolerability of Subcutaneous Cagrilintide.

Clinical pharmacokinetics

Pharmacovigilance Assessment of Thrombotic Adverse Events Linked to GLP-1 Receptor Agonists: Analysis of FAERS Reports from 2020-2025.

Current drug safety

Quadruple Non-Insulin Therapy for Advanced Type 2 Diabetes Mellitus With Cognitive Impairment: A Case Report.

Cureus

Hypercalcemia Induced by Tirzepatide and Calcium Supplementation: A Case Report.

Cureus

RT @TwicehoT: เผื่อคนขายปากกาปักไม่รู้ 🚨 ยากลุ่ม GLP-1 เช่น Semaglutide และ Tirzepatide ถูกยกระดับเป็น "ยาควบคุมพิเศษ" หลังจากกฎหมายมีผล…

📢 ผลเสียของการปักกาที่ไม่มีใครเตือน‼️ ⛔ระวังสูญเสียมวลกล้ามเนื้อและกระดูกพรุน ​ยากลุ่ม GLP-1 receptor agonists คือยาจำพวก เซมากลูไทด์ (Semaglutide - ชื่อการค้า Ozempic, Wegovy) และยาทิรเซพาไทด์ (Tirzepatide - ชื่อการค้า Mounjaro, Zepbound) จากการวิจัยภายใน 52 อาทิตย์ https://t.co/MoXEVORcgI

India’s GLP-1 market has exploded from ₹121 crore to ₹1,736 crore in four years. After semaglutide’s patent expiry on 20 March, 13 companies launched 26 brands within a week. Prices crashed from nearly ₹16,000 per month to as low as ₹1,290, with Glenmark pricing a weekly

RT @afshineemrani: 2/5 The study matched patients on GLP-1 receptor agonists — semaglutide, tirzepatide, liraglutide, and others — against…

1/ The word “peptide” has become almost meaningless on social media. Some peptides have decades of human data, known receptors, and FDA approval. Others are supported primarily by animal studies, mechanistic theories, and anecdotes. The most important takeaway from Dr. Abud https://t.co/VlySymIWg7

@nicknorwitz Imagine knee or shoulder surgery along with IV drip of BPC-157 pre, during, and post surgery recovery. 24hrs of peptide therapy. Hospital and fda approved. Maybe hgh and IGF as well.

The first 6 months on GLP-1 are easy. The last 15 pounds are where most people stall. Why does fat loss plateau around month 9, even on full-dose semaglutide or tirzepatide? And why can increasing the dose actually make things worse? We break down the biology behind GLP-1

RT @aestheticprimal: @pierre_koutani lots of talk about BPC-157 and TB-500 but none about actual peptide therapy Melittin kills cancer ce…